Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 48351-48400 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05383092
Adapted Physical Activity for Children Treated With Cancer and Insulin Sensitivity
NA
Recruiting
60 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05270213
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
PHASE1
Recruiting
164 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
14 locations
NCT05568966
Collection of Blood Samples for New Diagnostic Devices 2
NA
Recruiting
20,000 participants
Started: Jul 11, 2022 · Completed: Aug 20, 2026
5 conditions
1 sponsor
7 locations
NCT05106036
Preventing Cognitive Decline by Reducing BP Target Trial
NA
Recruiting
4,000 participants
Started: Jul 11, 2022 · Completed: Aug 31, 2025
3 conditions
4 sponsors
1 location
NCT05266066
Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation
NA
Recruiting
590 participants
Started: Jul 11, 2022 · Completed: Dec 1, 2026
2 conditions
7 sponsors
16 locations
NCT05467215
Can Brief Exposure to Hyperoxia Improve Function After Chronic Spinal Cord Injury?
EARLY_PHASE1
Recruiting
25 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT05463289
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
NA
Recruiting
500 participants
Started: Jul 11, 2022 · Completed: Oct 29, 2025
3 conditions
3 sponsors
1 location
NCT04496817
Enriched Eggs for Retina Health in Type 2 Diabetes
NA
Recruiting
60 participants
Started: Jul 11, 2022 · Completed: Sep 1, 2024
2 conditions
2 sponsors
1 location
NCT05181891
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
PHASE2
Recruiting
205 participants
Started: Jul 11, 2022 · Completed: May 1, 2026
2 conditions
1 sponsor
1 location
NCT05382572
Pulmonary Fibrosis Foundation Community Registry
N/A
Recruiting
10,000 participants
Started: Jul 11, 2022 · Completed: Jul 1, 2027
4 conditions
2 sponsors
1 location
NCT06599372
Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia
NA
Recruiting
30 participants
Started: Jul 11, 2022 · Completed: Nov 30, 2027
3 conditions
1 sponsor
1 location
NCT05288777
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
PHASE2/PHASE3
Recruiting
45 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2029
4 conditions
1 sponsor
1 location
NCT05329103
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
PHASE1
Recruiting
65 participants
Started: Jul 11, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
7 locations
NCT05075317
Time Restricted Eating and Cardiac Rehabilitation
NA
Recruiting
60 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05232136
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
PHASE1/PHASE2
Recruiting
30 participants
Started: Jul 11, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT04915248
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
PHASE2
Recruiting
28 participants
Started: Jul 11, 2022 · Completed: Jan 1, 2026
1 condition
2 sponsors
18 locations
NCT05420454
A Study for the Neoadjuvant Treatment of Breast Cancer
PHASE4
Recruiting
1,576 participants
Started: Jul 10, 2022 · Completed: Dec 20, 2027
1 condition
1 sponsor
1 location
NCT04685577
Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients
PHASE2
Recruiting
60 participants
Started: Jul 10, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05420467
A Study for the Adjuvant Treatment of Breast Cancer
PHASE4
Recruiting
2,413 participants
Started: Jul 10, 2022 · Completed: Dec 20, 2027
1 condition
1 sponsor
1 location
NCT05461664
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA
N/A
Recruiting
74 participants
Started: Jul 10, 2022 · Completed: Dec 31, 2025
3 conditions
22 sponsors
1 location
NCT04848636
Cardiac Tissue Sodium Assessment in CKD Patients Using Sodium MRI
N/A
Recruiting
150 participants
Started: Jul 10, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05447169
Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening
N/A
Recruiting
11,625 participants
Started: Jul 10, 2022 · Completed: Jul 1, 2030
1 condition
9 sponsors
1 location
NCT05722535
Using Shared Decision Making to Improve Family Media Use Planning
NA
Recruiting
300 participants
Started: Jul 10, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT07064746
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
N/A
Recruiting
150 participants
Started: Jul 10, 2022 · Completed: Jul 10, 2027
1 condition
2 sponsors
1 location
NCT05214859
Enhancing Mother-Child Ties and Psychosocial Wellness Through Arts Among Children With Intellectual Disability and Their Mothers
NA
Recruiting
154 participants
Started: Jul 9, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT05485077
A Prospective Cohort Study on Colorectal Cancer Screening in Community Population
N/A
Recruiting
18,000 participants
Started: Jul 9, 2022 · Completed: Jul 9, 2028
1 condition
2 sponsors
1 location
NCT05464875
A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
N/A
Recruiting
74 participants
Started: Jul 9, 2022 · Completed: Dec 31, 2025
3 conditions
22 sponsors
1 location
NCT05364606
Patient Specific Talus Spacer Post Approval Study
N/A
Recruiting
50 participants
Started: Jul 8, 2022 · Completed: Nov 30, 2029
1 condition
1 sponsor
6 locations
NCT05463133
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
PHASE1/PHASE2
Recruiting
50 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT04763109
Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
NA
Recruiting
15 participants
Started: Jul 8, 2022 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT05839106
Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
200 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT06321640
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
N/A
Recruiting
265 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2025
8 conditions
1 sponsor
1 location
NCT05262907
Ventripoint Single Ventricle Study
NA
Recruiting
100 participants
Started: Jul 8, 2022 · Completed: Aug 31, 2027
2 conditions
1 sponsor
1 location
NCT05113537
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
PHASE1/PHASE2
Recruiting
30 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2027
7 conditions
3 sponsors
1 location
NCT05469607
The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD
NA
Recruiting
13 participants
Started: Jul 8, 2022 · Completed: Jul 31, 2028
1 condition
5 sponsors
1 location
NCT06946264
Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features
PHASE3
Recruiting
400 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT05973656
Role of Acetaldehyde in the Development of Oral Cancer
NA
Recruiting
170 participants
Started: Jul 8, 2022 · Completed: Sep 30, 2027
3 conditions
2 sponsors
1 location
NCT05549921
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
PHASE2
Recruiting
70 participants
Started: Jul 8, 2022 · Completed: Sep 1, 2024
1 condition
2 sponsors
2 locations
NCT06653270
Virtual Reality Birth Simulator
NA
Recruiting
300 participants
Started: Jul 8, 2022 · Completed: Jul 30, 2025
4 conditions
1 sponsor
1 location
NCT05426681
Spinal Cord Injury Neuroprotection With Glyburide
PHASE1
Recruiting
12 participants
Started: Jul 7, 2022 · Completed: May 31, 2028
1 condition
1 sponsor
1 location
NCT05250466
A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia
NA
Recruiting
120 participants
Started: Jul 7, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05463536
Improvings: Implementing a Protocol to Improve Intrapartum Sonography Skills.
N/A
Recruiting
20 participants
Started: Jul 7, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT04674462
Understanding Poor Vaccine Responses to Hepatitis B Vaccination
PHASE4
Recruiting
200 participants
Started: Jul 7, 2022 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT05261477
Brain Injury Education and Outpatient Navigation-1stBIEN
NA
Recruiting
300 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
6 locations
NCT04982796
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
PHASE1/PHASE2
Recruiting
30 participants
Started: Jul 7, 2022 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT06245330
A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
180 participants
Started: Jul 7, 2022 · Completed: Aug 31, 2027
2 conditions
1 sponsor
1 location
NCT05226871
Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies
PHASE2
Recruiting
35 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
22 locations
NCT05440929
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
N/A
Recruiting
15 participants
Started: Jul 7, 2022 · Completed: Aug 10, 2027
2 conditions
2 sponsors
1 location
NCT05783804
Plaque Reversal With Early, Aggressive Lipid Lowering Therapy
N/A
Recruiting
60 participants
Started: Jul 7, 2022 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
NCT06012942
Prevalence and Long Term Effects of Frailty in Elderly Intensive Care Patients
N/A
Recruiting
300 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2025
2 conditions
6 sponsors
5 locations
Previous
1
More pages
965
966
967
968
969
970
971
More pages
1333
Next